Vaccine News and Research

Latest Vaccine News and Research

Study evaluates effectiveness of H1N1 vaccine in pregnant women against adverse infant outcomes

Pregnant women who received the H1N1 influenza vaccine during the 2009 pandemic were less likely to have premature babies, and their babies weighed more on average.

20 Feb 2013

First Edition: February 19, 2013

Kaiser Health News staff writer Jay Hancock, working in collaboration with The Philadelphia Inquirer, reports: "Computer mistakes like the one that produced incorrect prescriptions for thousands of Rhode Island patients are probably far more common and dangerous than the Obama administration wants you to believe, says Drexel University's Dr. Scot Silverstein."

19 Feb 2013

Vaccine prices and availability: an interview with Kate Elder, Vaccines Policy Advisor for Médecins Sans Frontières's Access Campaign

One of the key reasons why children are missed by immunization programs, particularly in developing countries where Médecins Sans Frontières (MSF) works, is that the products that we currently have in their present formulation are not well-suited to the places that have the most un-immunized children. These are the most challenging contexts to work in.

19 Feb 2013

New lab at Diamond to help scientists delve into inner workings of pathogens

The UK's national synchrotron facility, Diamond Light Source, is now the first and only place in Europe where pathogens requiring Containment Level 3 - including serious viruses such as those responsible for AIDS, Hepatitis and some types of flu - can be analysed at atomic and molecular level using synchrotron light.

18 Feb 2013

'Vaccine patch' could make immunizations cheaper, easier

"An innovative new way to deliver vaccines could drastically improve the health of the third world, and even the first world, by making vaccines cheaper and easier to distribute and use," Business Insider reports, adding, "The 'vaccine patch' would be as easy to apply as a Band-Aid, and would be stable for weeks at room temperature."

16 Feb 2013

Patients with untreated depression are poorly protected by shingles vaccination

Results from a new study published in Clinical Infectious Diseases suggest a link between untreated depression in older adults and decreased effectiveness of the herpes zoster, or shingles, vaccine.

16 Feb 2013

Depression reduces efficacy of shingles vaccine

Research suggests that the varicella zoster, or shingles, vaccine is less effective in older people with untreated depression.

15 Feb 2013

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

TB is an infectious disease caused by Mycobacterium tuberculosis. Nearly 9 million people develop TB every year, and TB kills nearly 1.4 million individuals each year. While the incidence of TB has steadily declined in the west, it remains a huge public health problem in many developing countries, with India having the highest burden.

15 Feb 2013

More polio workers killed than reported cases of disease, NPR reports

"The global effort to eradicate polio has reached a bizarre stage: More people have been gunned down recently over the disease than actually infected with it," NPR's "Shots" blog reports.

14 Feb 2013

Study finds human MPV as second most common cause of severe bronchiolitis in young children

New Vanderbilt-led research published in the Feb. 14 issue of the New England Journal of Medicine has identified the relatively unknown human metapneumovirus (MPV) as the second most common cause of severe bronchiolitis in young children.

14 Feb 2013

Blogs examine root causes, implications of myths about polio vaccination

Citing a review by Telegraph correspondent Rob Crilly criticizing the film Zero Dark Thirty "for getting its facts wrong about the CIA vaccination campaign that sought to confirm the DNA of Osama bin Laden's children," development blogger Tom Murphy writes in the Humanosphere blog, "Crilly's larger point is to say that the film gives further ammo to polio vaccine conspiracy theorists."

14 Feb 2013

FDA grants orphan drug status to Lentigen’s LG631-CD34 for treatment of glioblastoma multiforme

Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery products, announced today that that the U.S. Food and Drug Administration (FDA) has granted orphan drug status to P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells for bone marrow protection in the treatment of glioblastoma multiforme.

14 Feb 2013

Learning from India's success in eradicating polio

In a post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Shelley Thakral, senior communications officer for the foundation's India Country Office, interviews Orin Levine, director of vaccine delivery at the foundation, about his recent trip to India "to observe the experience of Bihar, a state in Northern India, where the polio effort is now being leveraged to strengthen routine immunization in ways that are really exciting."

13 Feb 2013

U.N. Secretary General condemns violence against health workers in Nigeria

U.N. Secretary-General Ban Ki-moon on Monday "strongly condemned the killing in north-eastern Nigeria of three doctors from the Democratic People's Republic of Korea, calling the attack and other recent incidents of violence against health workers 'unacceptable,'" the U.N. News Centre reports.

13 Feb 2013

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

Metastatic renal cell carcinoma is a devastating disease. There are roughly 20-25,000 new cases per year in the United States and it is increasing for some reason.

12 Feb 2013

Examining efforts to integrate cervical cancer screening, treatment into HIV services in Zambia

In the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog, Janet Fleischman and Julia Nagel of CSIS discuss "the opportunities and challenges of integrating cervical cancer screening and treatment into HIV services for women," with a focus on the efforts of Zambia.

12 Feb 2013

Three North Korean doctors killed in Nigeria; Government, U.N. agencies condemn murders of polio workers

"Three North Korean doctors have been killed in a pre-dawn attack in Nigeria's northeastern town of Potiskum, police say," but "[t]he motive of Sunday's attack was not immediately clear," Al Jazeera reports.

12 Feb 2013

PharmaJet receives Performance, Quality and Safety pre-qualified certification from WHO

PharmaJet Inc. has become the first and only needle-free injection company to receive Performance, Quality and Safety (PQS) pre-qualified certification from the World Health Organization (WHO).

12 Feb 2013

Individualized flu immune responses revealed by high-throughput sequencing

Researchers have shown that it is possible to create personalized, individual-specific measurements of the antibody repertoire in response to influenza vaccination using high-throughput DNA sequencing technology.

11 Feb 2013

Nine polio workers killed in northern Nigeria

"Nine female polio vaccinators have been killed in two shootings at health centers in northern Nigeria, police have told the BBC," the news agency reports. "In the first attack in Kano the polio vaccinators were shot dead by gunmen who drove up on a motor tricycle," and "[t]hirty minutes later gunmen targeted a clinic outside Kano city as the vaccinators prepared to start work," BBC News writes.

11 Feb 2013

Vaccine News and Research

Latest Vaccine News and Research

Study evaluates effectiveness of H1N1 vaccine in pregnant women against adverse infant outcomes

First Edition: February 19, 2013

Vaccine prices and availability: an interview with Kate Elder, Vaccines Policy Advisor for Médecins Sans Frontières's Access Campaign

New lab at Diamond to help scientists delve into inner workings of pathogens

'Vaccine patch' could make immunizations cheaper, easier

Patients with untreated depression are poorly protected by shingles vaccination

Depression reduces efficacy of shingles vaccine

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

More polio workers killed than reported cases of disease, NPR reports

Study finds human MPV as second most common cause of severe bronchiolitis in young children

Blogs examine root causes, implications of myths about polio vaccination

FDA grants orphan drug status to Lentigen’s LG631-CD34 for treatment of glioblastoma multiforme

Learning from India's success in eradicating polio

U.N. Secretary General condemns violence against health workers in Nigeria

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

Examining efforts to integrate cervical cancer screening, treatment into HIV services in Zambia

Three North Korean doctors killed in Nigeria; Government, U.N. agencies condemn murders of polio workers

PharmaJet receives Performance, Quality and Safety pre-qualified certification from WHO

Individualized flu immune responses revealed by high-throughput sequencing

Nine polio workers killed in northern Nigeria

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in